Effect of upper gastrointestinal endoscopy on circulation in the elderly.
BACKGROUND
Upper gastrointestinal endoscopy in the elderly is increasingly becoming more common, despite the possibility that a minimal load on the circulation can cause serious complications such as shock and cardiac arrest.


OBJECTIVE
The effects of endoscopy on the heart and the possibility of predicting circulatory accidents were studied using natriuretic peptide levels.


METHODS
The patients were randomly chosen according to their age and divided into an elderly group (over 60 years of age, 64 patients) and a young group (under 30 years of age, 20 patients). The patients in the elderly group were further subdivided into two groups based on the presence or absence of circulatory complications (46 patients with circulatory complications and 18 without complications). The load on the heart was evaluated by measuring human atrial natriuretic peptide (hANP) and human brain natriuretic peptide (hBNP) which are secreted by the myocardial cells in response to cardiac load. Specimens were obtained before and after endoscopy.


RESULTS
The hANP level was significantly higher after endoscopy in the elderly group, regardless of the presence or absence of circulatory complications. No significant difference was observed in the hBNP level. No significant increase in hANP or hBNP levels was observed after endoscopy in the young group.


CONCLUSIONS
These observations suggest an increased atrial load during endoscopy in the elderly. The increase in pulse rate during endoscopy is one possible cause of atrial load. Therefore, the risk of circulatory system damage must be recognized when endoscopy is performed in the elderly. The measurement of plasma hANP and hBNP levels may provide effective indices for evaluating cardiac load during endoscopy.
2nd Department of Internal Medicine, Osaka Medical College, Osaka, Japan. in2021@poh.osaka-med.ac.jp
C
C
Shimamoto
I
I
Hirata
K
K
Katsu
D000328:Adult; D000368:Aged; D000375:Aging; D016275:Atrial Function; D009320:Atrial Natriuretic Factor / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D018680:Cholinergic Antagonists / Q000008:administration & dosage; D016099:Endoscopy, Gastrointestinal / Q000009:adverse effects*; D004837:Epinephrine / Q000097:blood; D006323:Heart Arrest / Q000209:etiology / Q000517:prevention & control; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics; D006801:Humans; D008875:Middle Aged; D009218:Myosins / Q000097:blood; D020097:Natriuretic Peptide, Brain / Q000097:blood; D009638:Norepinephrine / Q000097:blood; D012769:Shock / Q000209:etiology / Q000517:prevention & control; D020107:Troponin T / Q000097:blood
D018680:Cholinergic Antagonists; D020107:Troponin T; D020097:Natriuretic Peptide, Brain; D009320:Atrial Natriuretic Factor; D009218:Myosins; D009638:Norepinephrine; D004837:Epinephrine